In case you follow big pharma you probably heard of Novartis' recent failed Phase 3 study of pelacarsen, an oligonucleotide that was designed to interfere with the production of Lipoprotein A, and it did just that, it was great at doing that, but people died of cardiovascular disease anyway, which ofc is why it failed.
It sank the stock from 160 down to under 140 due to the high expectations that the drug would become the final nail in the coffin of the dangerous lipoproteins, the awful cohort that statins in the form of first Lipitor started fighting. Lipitor generated the largest haul of any small-molecule drug in history, eclipsing even the total of Losec and Nexium.
So yeah, the prospect of Novartis managing to target a population of more than a billion people suffering from elevated Lp(a) levels created enough expectations to crash even the stock of a giant like Novartis.
But let's circle back to the fact that getting Lp(a) under control didn't lower the risk of CVD. How come? I'm sure the medical establishment already has a lot of post-hoc explanations like the participants in the study were too old, already too sick, already on statins and blood pressure lowering drugs which already protects against MACE, all of which logically would interfere with the effectiveness of the study, or muddy the waters. What would really settle it is a longitudinal study over decades on people who start out with excellent cardiovascular health, but that is the purview of nation states that don't have a profit motive and more cash than poor Novartis, also patent cliffs and all that.
I have an idea: let's just focus on making sure that the lipids don't enter the inner lining of the blood vessels in the first place shall we?
And as chance has it, I had personally already done that before I discovered that I had 800 mg of Lp(a) per liter of blood (100-200 is normal). Yet my carotid intima media thickness is 0.55 mm despite me being 50 years old, I also have zero calcification.
I managed that by eating less starch and sugars than a normal person does, that is basically it. I started doing that in roughly 2002 and I haven't even been particularly conscientious, I've had literal cheat years when I ate mainly white rice like any South East Asian person would, plus a couple of beers per week on top of that.
But I always gravitated back to more fiber and less carbs, and that probably saved my life.
The problem is that the human body is unreasonably effective at digesting starches, they don't taste like candy and many feel fairly wholesome, like oatmeal. They're not, they'll spike your insulin levels and in the end cause insulin resistance which in turn causes CVD by making the inner linings inflamed and more permeable and when that happens it doesn't matter if you're on pelacarsen, statins etc or not, the lipids that are left will be enough to mess up your arterial walls. It's just a matter of speed, plus the other complications that lipid lowering meds don't improve are not nice either.
But don't take my word for it, you can watch Dr. Ford Brewer that ran the program at Johns Hopkins for Preventive Medicine say roughly what I'm writing here with regards to diet.
However, despite eating a lot of fiber and being on a low carb diet I eventually ended up getting a minor ischemic stroke (Lp(a) caused a minor blod clot due to its propensity to make platelets stick together, stellar vessel linings are irrelevant in this context, unfortunately) during the Christmas break two years ago and am now on baby aspirin, I also did a PFO closure. Recurring bouts of silent migraines with aura were a common occurrence in my life before the baby aspirin and PFO closure, they have now completely stopped. What I am not eating is statins though, I tried and they gave me restless leg syndrome. Plus, just like pelacarsen, they would probably not be particularly beneficial for someone like me anyway.
The last few years has seen a sharp drop in alcohol consumption, at least in the west, making for instance Diageo a victim of changing mores, or perhaps GLP-1 drugs. There's also talk of putting on long term shorts on companies like Hershey to ride this as a long term trend. Whether it is increased awareness and willingness to get off of crap food, or GLP-1s auto-accomplishing effectively the same thing is besides the point, the point is that this is happening and not stopping.
I haven't seen this idea before: what if unlike pelacarsen, which flamed out, we will instead see most of the CVD drugs under development go out with a whimper due to a disappearing TAM, i.e. they go the way of Diageo?
Head over to the GraphSeam search and search for "cardiovascular", maybe you'll find some nice short candidates there.
Get new posts by email
No spam, unsubscribe any time. Or follow via RSS